中望软件：10月24日召开董事会会议

Group 1 - The core point of the article is that Zhongwang Software (SH 688083) held its 20th meeting of the 6th board of directors on October 24, 2025, to review the proposal for the company's Q3 2025 report [1] - For the year 2024, Zhongwang Software's revenue composition is 99.86% from the software industry and 0.14% from other businesses [1] - As of the report date, Zhongwang Software has a market capitalization of 13.4 billion yuan [1] Group 2 - The article highlights that China's innovative pharmaceuticals have generated $80 billion in overseas licensing deals this year [1] - It discusses the current hot market in the secondary sector of biomedicine while noting that fundraising in the primary market is facing challenges [1]